Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
Recruiting · NCT06177067 · Registry updated 2026-08-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute biphenotypic leukemia, acute leukemia of ambiguous lineage, acute myeloid leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-08-03 | NCT06177067 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| St. Jude Children's Research Hospital | 169 |
| Syndax Pharmaceuticals | 16 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's Healthcare of Atlanta | Atlanta | United States | 38 |
| Children's Hospital Colorado | Aurora | United States | 312 |
| Children's Hospital of Philadelphia | Philadelphia | United States | 434 |
| Children's Mercy Hospital of Kansas City | Kansas City | United States | 1 |
| Cincinnati Children's Hospital Medical Center | Cincinnati | United States | 405 |
| Cook Children's Medical Center | Fort Worth | United States | 111 |
| Memorial Sloan- Kettering Cancer Center | New York | United States | 1 |
| Rady Children's Hospital | San Diego | United States | 1 |
| St. Jude Children's Research Hospital | Memphis | United States | 194 |
| UT Southwestern/Simmons Cancer Center | Dallas | United States | 3 |